PharmaSGP Holding SE

DB:PSG Stock Report

Market Cap: €302.2m

PharmaSGP Holding Future Growth

Future criteria checks 3/6

PharmaSGP Holding is forecast to grow earnings and revenue by 14.6% and 7% per annum respectively. EPS is expected to grow by 13.7% per annum. Return on equity is forecast to be 40.7% in 3 years.

Key information

14.6%

Earnings growth rate

13.7%

EPS growth rate

Pharmaceuticals earnings growth19.5%
Revenue growth rate7.0%
Future return on equity40.7%
Analyst coverage

Low

Last updated02 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:PSG - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261312633342
12/31/20251212230322
12/31/20241121825272
6/30/2024110182122N/A
3/31/2024107182628N/A
12/31/2023101162627N/A
9/30/202398152526N/A
6/30/202394142223N/A
3/31/202389132828N/A
12/31/202286122425N/A
9/30/202283113435N/A
6/30/20228111-6419N/A
3/31/20227411-7112N/A
12/31/20216511-7112N/A
9/30/2021618-89-6N/A
6/30/202156888N/A
3/31/20215991213N/A
12/31/202063111515N/A
9/30/202065161819N/A
6/30/202065171718N/A
3/31/202064172020N/A
12/31/201963171718N/A
12/31/2018611588N/A
12/31/20175312N/A14N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PSG's forecast earnings growth (14.6% per year) is above the savings rate (1%).

Earnings vs Market: PSG's earnings (14.6% per year) are forecast to grow slower than the German market (20.7% per year).

High Growth Earnings: PSG's earnings are forecast to grow, but not significantly.

Revenue vs Market: PSG's revenue (7% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: PSG's revenue (7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PSG's Return on Equity is forecast to be very high in 3 years time (40.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y